Publications dans lesquelles il/elle collabore avec Luis Madero López (56)

2022

  1. Melanoma en niños prepuberales:: dificultades diagnósticas y terapéuticas

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 96, Núm. 4, pp. 352-357

  2. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

2020

  1. Can monitoring asparaginase activity help us to manage toxicity in pediatric acute lymphoblastic leukemia?

    Leukemia and Lymphoma

  2. First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors

    Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042

  3. Gemcitabine, paclitaxel, and oxaliplatin (GEMPOX) in the treatment of relapsed/refractory intracranial nongerminomatous germ cell tumors

    Pediatric Blood and Cancer, Vol. 67, Núm. 2

  4. Genetic and immune changes associated with disease progression under the pressure of oncolytic therapy in a neuroblastoma outlier patient

    Cancers, Vol. 12, Núm. 5

  5. Inhospital exercise benefits in childhood cancer: A prospective cohort study

    Scandinavian Journal of Medicine and Science in Sports, Vol. 30, Núm. 1, pp. 126-134

  6. Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic

    Pediatric Blood and Cancer

  7. Treatment of radiation-induced myelopathy with bevacizumab

    Clinical and Translational Oncology

2019

  1. Improving the quality of care in the molecular era for children and adolescents with medulloblastoma

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1687-1698

  2. Old drugs still work! Oral etoposide in a relapsed medulloblastoma

    Child's Nervous System, Vol. 35, Núm. 5, pp. 865-869

2018

  1. Retraso en la eliminación de metotrexato y su monitorización tras el uso de carboxipeptidasa-G2

    Actualidad en farmacología y terapéutica, Vol. 16, Núm. 2, pp. 93-95

  2. Tumor de Wilms: Revisión de nuestra experiencia en los últimos 15 años

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 88, Núm. 3, pp. 140-149

2017

  1. Dicentric translocation (9;12) in acute lymphoblastic leukemia: A chromosomal abnormality with an excellent prognosis?

    Tumori, Vol. 103, pp. S44-S46

  2. Dos hermanos con leucemia linfoblástica aguda: ¿casualidad o herencia?

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 87, Núm. 3, pp. 170-171

  3. Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update

    Cancer Medicine, Vol. 6, Núm. 11, pp. 2606-2624

  4. Tumores germinales intracraneales: Revisión de 21 años

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 86, Núm. 1, pp. 20-27

2016

  1. Hemiparesis in an adolescent with Acute lymphoblastic leukemia: Everything is not always what it seems

    Journal of Pediatric Hematology/Oncology, Vol. 38, Núm. 1, pp. 63-64

  2. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells

    Cancer Letters, Vol. 371, Núm. 2, pp. 161-170

2015

  1. All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy

    Pediatric Hematology and Oncology, Vol. 32, Núm. 3, pp. 193-198